133 related articles for article (PubMed ID: 2468860)
1. Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
Faulhaber HD; Gruner R; Homuth V; Naumann E; Menz M; Hartrodt W; Schmidt J; Mohnike W
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S146-8. PubMed ID: 2468860
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
Johnson BF; Romero L; Marwaha R
Clin Pharmacol Ther; 1986 Apr; 39(4):389-94. PubMed ID: 2937598
[TBL] [Abstract][Full Text] [Related]
3. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of nitrendipine in severe essential hypertension.
Burris JF; Nash DT; Mroczek WJ
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S157-60. PubMed ID: 2468863
[TBL] [Abstract][Full Text] [Related]
5. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
[TBL] [Abstract][Full Text] [Related]
6. Prolonged calcium channel blocker therapy of hypertension.
Weber MA
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S16-21. PubMed ID: 2468864
[TBL] [Abstract][Full Text] [Related]
7. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
Weber MA; Drayer JI
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
[TBL] [Abstract][Full Text] [Related]
8. Nitrendipine as an antihypertensive agent.
Zachariah PK
Eur Heart J; 1987 Nov; 8 Suppl K():63-7. PubMed ID: 3330031
[TBL] [Abstract][Full Text] [Related]
9. Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension.
Drayer JI; Hall WD; Smith VE; Weber MA; Wollam GL; White WB
Clin Pharmacol Ther; 1986 Dec; 40(6):679-85. PubMed ID: 3780130
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
[TBL] [Abstract][Full Text] [Related]
11. Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension.
Giles TD; Sander GE; Roffidal LC; Thomas MG; Given MB; Quiroz AC
Am J Cardiol; 1987 Jul; 60(1):103-6. PubMed ID: 3300241
[TBL] [Abstract][Full Text] [Related]
12. Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group.
Krönig B; Pittrow DB; Kirch W; Welzel D; Weidinger G
Hypertension; 1997 Feb; 29(2):651-8. PubMed ID: 9040452
[TBL] [Abstract][Full Text] [Related]
13. The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.
Maltz MB; Davies DW; Lau CP; Creamer JE; Banim SO; Camm AJ
Br J Clin Pharmacol; 1986 Oct; 22(4):463-7. PubMed ID: 3533128
[TBL] [Abstract][Full Text] [Related]
14. Long-term antihypertensive effects and safety of nitrendipine in patients with mild, moderate, and severe hypertension.
Kann J
J Clin Pharmacol; 1987 Dec; 27(12):945-50. PubMed ID: 3437066
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a new calcium antagonist in severe hypertension.
Burris JF; Santangelo RP; Mroczek WJ
J Clin Pharmacol; 1986; 26(8):593-7. PubMed ID: 3793949
[TBL] [Abstract][Full Text] [Related]
16. Similar efficacy of nitrendipine in young and elderly hypertensive patients.
Mehta J; Lopez LM; Deedwania PC; Fagan TC; Sternlieb CM; Vlachakis ND; Birkett JP; Schwartz LA
Am J Cardiol; 1987 Nov; 60(13):1096-100. PubMed ID: 3314459
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of essential arterial hypertension with nitrendipine.
Uslenghi E; Minelli M; Bo L; Avogliero G; Amerio S; Rocci R; Borgnino C
Clin Ther; 1988; 10(2):169-77. PubMed ID: 3273864
[TBL] [Abstract][Full Text] [Related]
18. Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension.
Lopez LM; Mehta JL; Baz R; Aguila E
Clin Pharmacol Ther; 1984 Oct; 36(4):444-50. PubMed ID: 6478732
[TBL] [Abstract][Full Text] [Related]
19. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
[TBL] [Abstract][Full Text] [Related]
20. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
Aoki K; Sato K
Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
